Osteogenic potential of the human bone morphogenetic protein 2 gene activated nanobone putty

被引:0
|
作者
TIAN XiaobinSUN LiYANG ShuhuaZHANG YukunHU Ruyin and FU Dehao Department of OrthopedicsPeoples Hospital of Guizhou ProvinceGuiyangGuizhou China Department of OrthopedicsAffiliated Union HospitalTongji Medical College of Huazhong Science and Technology University WuhanHubei China [550002 ,430022 ]
机构
关键词
D O I
暂无
中图分类号
R318.0 [一般性问题];
学科分类号
摘要
Background Nanobone putty is an injectable and bioresorbable bone substitute.The neutral-pH putty resembles hard bone tissue,does not contain polymers or plasticizers,and is self-setting and nearly isothermic,properties which are helpful for the adhesion,proliferation,and function of bone cells.The aim of this study was to investigate the osteogenic potential of human bone morphogenetic protein 2(hBMP2) gene activated nanobone putty in inducing ectopic bone formation,and the effects of the hBMP2 gene activated nanobone putty on repairing bone defects. Methods Twenty four Kunming mice were randomly divided into two groups.The nanobone putty+hBMP2 plasmid was injected into the right thigh muscle pouches of the mice(experiment side).The nanobone putty+blank plasmid or nanobone putty was injected into the left thigh muscle pouches of the group 1(control side 1) or group 2(control side 2), respectively.The effects of ectopic bone formation were evaluated by radiography,histology,and molecular biology analysis at 2 and 4 weeks after operation.Bilateral 15 mm radial defects were made in forty-eight rabbits.These rabbits were randomly divided into three groups:Group A,nanobone putty+hBMP2 plasmid;Group B,putty+blank plasmid; Group C,nanobone putty only.Six rabbits with left radial defects served as blank controls.The effect of bone repairing was evaluated by radiography,histology,molecular biology,and biomechanical analysis at 4,8,and 12 weeks after operation. Results The tissue from the experimental side of the mice expressed hBMP2.Obvious cartilage and island-distributed immature bone formation in implants of the experiment side were observed at 2 weeks after operation,and massive mature bone observed at 4 weeks.No bone formation was observed in the control side of the mice.The ALP activity in the experiment side of the mice was higher than that in the control side.The tissue of Group A rabbits expressed hBMP2 protein and higher ALP level.The new bone formation rate and antibending strength of group A was significantly higher than those of group B and C.The defects in blank control were not healed. Conclusions The hBMP2 gene activated nanobone putty exhibited osteoinductive ability,and had a better bone defect repair capability than that of nanobone putty only.
引用
收藏
页码:745 / 751
相关论文
共 50 条
  • [31] First experiences with recombinant human bone morphogenetic protein 7 (osteogenic protein 1) in a human case in maxillofacial surgery
    Warnke, PH
    Coren, AJ
    PLASTIC AND RECONSTRUCTIVE SURGERY, 2003, 111 (07) : 2471 - 2472
  • [32] Human chondrocyte responsiveness to bone morphogenetic protein-2 after their in vitro dedifferentiation: Potential use of bone morphogenetic protein-2 for cartilage cell therapy
    Salentey, V.
    Claus, S.
    Bougault, C.
    Paumier, A.
    Aubert-Foucher, E.
    Perrier-Groult, E.
    Ronziere, M. -C.
    Freyria, A. -M.
    Galera, P.
    Beauchef, G.
    Duterque-Coquillaud, M.
    Piperno, M.
    Damour, O.
    Herbage, B.
    Mallein-Gerin, F.
    PATHOLOGIE BIOLOGIE, 2009, 57 (04): : 282 - 289
  • [33] Bone morphogenetic protein gene therapy
    Alden, TD
    Varady, P
    Kallmes, DF
    Jane, JA
    Helm, GA
    SPINE, 2002, 27 (16) : S87 - S93
  • [34] Marker Gene Screening for Human Mesenchymal Stem Cells in Early Osteogenic Response to Bone Morphogenetic Protein 6 with DNA Microarray
    Zou, Shien
    Zhang, Shaofen
    Long, Qiqi
    Cao, Yuankui
    Zhang, Wei
    GENETIC TESTING AND MOLECULAR BIOMARKERS, 2013, 17 (08) : 641 - 645
  • [35] In Vitro Osteogenic Differentiation Enhanced by Zirconia Coated with Bone Morphogenetic Protein-2
    Kim, Eun-Cheol
    Yang, Dae Hyeok
    Lee, Deok-Won
    JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY, 2017, 17 (02) : 998 - 1007
  • [36] The osteogenic effect of bone morphogenetic protein-2 on the collagen scaffold conjugated with antibodies
    Zhao, Yannan
    Zhang, Jing
    Wang, Xia
    Chen, Bin
    Xiao, Zhifeng
    Shi, Chunying
    Wei, Zhanliang
    Hou, Xianglin
    Wang, Qiangbin
    Dai, Jianwu
    JOURNAL OF CONTROLLED RELEASE, 2010, 141 (01) : 30 - 37
  • [37] Role of bone morphogenetic protein-2 in osteogenic differentiation of mesenchymal stem cells
    Sun, Jian
    Li, Jieyun
    Li, Chichi
    Yu, Youcheng
    MOLECULAR MEDICINE REPORTS, 2015, 12 (03) : 4230 - 4237
  • [38] Osteogenic differentiation of human mesenchymal stem cells is regulated by bone morphogenetic protein-6
    Friedman, Michael S.
    Long, Michael W.
    Hankenson, Kurt D.
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2006, 98 (03) : 538 - 554
  • [39] Bone morphogenetic protein-2 decorated silk fibroin films induce osteogenic differentiation of human bone marrow stromal cells
    Karageorgiou, V
    Meinel, L
    Hofmann, S
    Malhotra, A
    Volloch, V
    Kaplan, D
    JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A, 2004, 71A (03) : 528 - 537
  • [40] Therapeutic Potential for Bone Morphogenetic Protein 4 in Human Malignant Glioma
    Xi, Guifa
    Best, Benjamin
    Mania-Farnell, Barbara
    James, Charles David
    Tomita, Tadanori
    NEOPLASIA, 2017, 19 (04): : 261 - 270